Posted on July 15, 2009 by blogfrogger
ScienceDaily — Researchers from Boston University School of Medicine (BUSM) in collaboration with scientists at the University of Louisville and the University of Nice Sophia Antipolis in France, have identified the target antigen PLA2R in patients with idiopathic membranous nephropathy (kidney disease), which has implications for the diagnosis and treatment of this disease. These findings appear in the July 2 issue of the New England Journal of Medicine.
Please click here for more information
Please visit LifeAlysis for current renal news and information
Filed under: Chronic Kidney Disease | Tagged: Chronic Kidney Disease | Leave a Comment »
Posted on July 15, 2009 by blogfrogger
Posted on July 15, 2009 by blogfrogger
Posted on July 15, 2009 by blogfrogger
Posted on July 15, 2009 by blogfrogger
Posted on June 24, 2009 by blogfrogger
Hemodialysis International-Kidney/Disease Outcome Quality Initiative (K/DOQI) guidelines recommend baseline echocardiography at the initiation of dialysis and every 3 years thereafter in patients for early detection of cardiac disease to optimize medical therapy. Because dialysis patients are at increased cardiovascular risk and thus most are already on cardioprotective medications, we hypothesize that serial screening echocardiography will not alter cardioprotective medications in dialysis patients.
Click here for more information
Please visit LifeAlysis for current renal news and information
Filed under: Hemodialysis Patients, Medical Journals | Tagged: Hemodialysis Patients | Leave a Comment »
Posted on June 24, 2009 by blogfrogger
Posted on June 24, 2009 by blogfrogger
Posted on June 24, 2009 by blogfrogger
Posted on June 22, 2009 by blogfrogger